Table 1 Development of RLN metastasis over time in an in vivo model of orthotopic endometrial cancer
The frequency of metastasized/examined lymph nodes (n = 6 per time point) | ||||||
|---|---|---|---|---|---|---|
No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | |
Post-injection | ||||||
15 D | 0/1 | 0/1 | 0/2 | 0/1 | 0/1 | 0/2 |
18 D | 0/3 | 0/3 | 0/2 | 0/1 | 0/1 | 0/2 |
21 D | 1/3 | 0/3 | 0/3 | 2/3 | 0/3 | 1/3 |
24 D | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 |
27 D | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 |
30 D | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 |